Cargando…
Mepolizumab in allergic bronchopulmonary aspergillosis complicated by infection
Allergic bronchopulmonary aspergillosis (ABPA) is an allergic reaction caused by the fungus Aspergillus, and it is often treated with steroids or antifungal agents. However, long-term use of these medications can lead to infections and drug interactions. We present the case of a 71-year-old woman wi...
Autores principales: | Hamada, Toru, Katsuta, Tomoya, Aibara, Kento, Nozu, Shohei, Nakamura, Junya, Kondo, Haruka, Tachibana, Sayaka, Inoue, Koji, Nakanishi, Norihiko, Moritaka, Tomonori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407267/ https://www.ncbi.nlm.nih.gov/pubmed/37560613 http://dx.doi.org/10.1016/j.rmcr.2023.101890 |
Ejemplares similares
-
A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab
por: Terashima, Takeshi, et al.
Publicado: (2018) -
Mepolizumab use in cystic fibrosis‐associated allergic bronchopulmonary aspergillosis
por: Boyle, Maeve, et al.
Publicado: (2020) -
Successful Treatment of Mepolizumab- and Prednisolone-resistant Allergic Bronchopulmonary Aspergillosis with Dupilumab
por: Mikura, Sunao, et al.
Publicado: (2021) -
Allergic bronchopulmonary aspergillosis successfully treated with mepolizumab: Case report and review of the literature
por: Hirota, Shuko, et al.
Publicado: (2018) -
Allergic bronchopulmonary aspergillosis complicated by eosinophilic chronic rhinosinusitis successfully treated with mepolizumab
por: Matsumoto, Nobuhiro, et al.
Publicado: (2019)